0001123292-18-001056.txt : 20181107
0001123292-18-001056.hdr.sgml : 20181107
20181107161038
ACCESSION NUMBER: 0001123292-18-001056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181106
FILED AS OF DATE: 20181107
DATE AS OF CHANGE: 20181107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oki Mark K
CENTRAL INDEX KEY: 0001491847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33389
FILM NUMBER: 181166419
MAIL ADDRESS:
STREET 1: C/O ALEXZA PHARMACEUTICALS INC
STREET 2: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIVUS INC
CENTRAL INDEX KEY: 0000881524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943136179
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 E. HAMILTON AVENUE
STREET 2: SUITE 550
CITY: CAMPBELL
STATE: CA
ZIP: 95008
BUSINESS PHONE: 6509345200
MAIL ADDRESS:
STREET 1: 900 E. HAMILTON AVENUE
STREET 2: SUITE 550
CITY: CAMPBELL
STATE: CA
ZIP: 95008
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-11-06
0000881524
VIVUS INC
VVUS
0001491847
Oki Mark K
C/O VIVUS, INC.
900 E. HAMILTON AVE., SUITE 550
CAMPBELL
CA
95008
0
1
0
0
Chief Financial Officer & CAO
Common Stock
2018-11-06
4
P
0
10000
4.07
A
10000
D
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $4.068 to $4.090. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
/s/ Julie Hollenback, Attorney-in-Fact
2018-11-07